Nemocnice Slany

Futó vizsgálatok

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Forrás

• Toboroz

  Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis

  NCT07686081· 3. fázis· Forrás

• Toboroz

  A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)

  2025-524404-29-00· 2. fázis· Forrás

• Toboroz

  Confirmatory Clinical Study in Active Ulcerative Colitis

  NCT07296315· 2. fázis· Forrás

• Toboroz

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· 2. fázis· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)

  2024-516652-18-00· 3. fázis· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)

  2024-516654-22-00· 3. fázis· Forrás

• Toboroz

  A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)

  2024-518296-56-00· 3. fázis· Forrás

• Felfüggesztve

  CRF2 Agonist for the Treatment of Worsening Heart Failure

  NCT06815471· 2. fázis· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative Colitis

  NCT06975722· 2. fázis· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Forrás

• Toboroz

  A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

  NCT06958536· 2. fázis· Forrás

• Toboroz

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· 3. fázis· Forrás

• Toboroz

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  NCT06742723· 3. fázis· Forrás

• Toboroz

  Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  NCT06456593· 2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  NCT06430801· 3. fázis· Forrás

• Fut, nem toboroz

  HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation.

  NCT05636176· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Forrás

• Fut, nem toboroz

  ABTECT - Maintenance

  NCT05535946· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

  NCT05668013· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

  NCT05197049· 3. fázis· Forrás

• Fut, nem toboroz

  Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

  NCT05177835· 2. fázis· Forrás

• Fut, nem toboroz

  Effects of ABX464 during long-term treatment in patients with moderate to severe ulcerative colitis

  2023-507974-42-00· 2. fázis· Forrás

• Fut, nem toboroz

  Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation

  NCT04755283· 2. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Colitis ulcerosa4 toboroz
• Crohn-betegség3 toboroz
• Elhízás3 toboroz
• Szívelégtelenség3 toboroz
• Krónikus vesebetegség1 toboroz
• Magas vérnyomás1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A study to compare the effect of AVT16 and Entyvio® in subjects with moderate to severe active ulcerative colitis.

  2023-507705-34-00· 3. fázis· Forrás

• Lezárult

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· 2. fázis· Forrás

• Lezárult

  A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis

  NCT06867094· 2. fázis· Forrás

• Toboroz

  An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis

  2023-507853-13-00· 2. fázis· Forrás

• Lezárult

  A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06049017· 2. fázis· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Forrás

• Lezárult

  Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

  2024-517612-29-00· 4. fázis· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Forrás

• Lezárult

  ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

  NCT05507203· 3. fázis· Forrás

• Lezárult

  A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

  NCT05499130· 2. fázis· Forrás

• Lezárult

  VTX002 versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

  2023-509233-39-00· 2. fázis· Forrás

• Lezárult

  A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

  NCT05093933· 3. fázis· Forrás

• Lezárult

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· 3. fázis· Forrás

• Lezárult

  Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

  NCT04607837· 2. fázis· Forrás

• Lezárult

  An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

  NCT02531126· 3. fázis· Forrás